CD44-targeted PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-17-3871

Related search